Investors / United States / Luma Group
Luma Group
Venture capital · New York, NY, United States · North America
Luma Group is a multistage investment firm focused on biotechnology. It combines scientific insight with its AI system, LABI, to analyze data and back companies developing therapies, diagnostics, and medical devices.
Invests inHealthcare & Biotech
In its own wordsbiotechnologytherapeuticsdiagnosticsmedical devicesprecision medicineai
Your fit with Luma Group
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsLuma Group lists 8 checked portfolio companies on its own site and is named in 4 funding rounds, 2 of them as lead. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (88%) and Media & Entertainment (13%). 86% of its companies are based in United States. It invests most often alongside ARCH Venture Partners, KdT Ventures and Sofinnova.
Counts come from funding rounds that name Luma Group, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundLuma Group does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 2 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 15th | 8 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 100th | 50% of companies confirmed by a round |
| Sector focus | 95th | 88% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| ARCH Venture Partners | 2 |
| KdT Ventures | 2 |
| Sofinnova | 2 |
| 8VC | 1 |
| Alta Partners | 1 |
| Altitude Life Science Ventures | 1 |
| Apollo Health Ventures | 1 |
| Arkam Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers8100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 88% | 15% |
| Media & Entertainment | 13% | 4% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with ARCH Venture Partners
Compare Luma Group head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Luma Group| Date | Company | Stage |
|---|---|---|
| 28 Apr 2026 | Series A | |
| 16 Dec 2025 | Series B Led | |
| 29 Oct 2025 | Series A Led | |
| 25 Mar 2025 | Series B |
Round details for Luma Group
Amounts, full round histories and every co-investor in Luma Group's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
8 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aeovian Pharmaceuticals develops small molecules to treat certain rare genetic and age-related diseases | Healthcare & Biotech | Dec 2025Series B | Page + round | |
| Altos Labs is focused on understanding how to translate the science of cell rejuvenation to help people live healthier lives. | Healthcare & Biotech | Portfolio page | ||
| Arsenal Biosciences, Inc. is a cell therapy company that discovers and develops next-generation in vivo T cell therapies to address chronic disease, including cancer and autoimmunity. | Healthcare & Biotech | Portfolio page | ||
| Character Bio is a clinical-stage biotechnology company developing new medicines for eye diseases | Healthcare & Biotech | Mar 2025Series B | Page + round | |
| Apr 2026Series A | Page + round | |||
| Curve Biosciences monitors chronic diseases using Whole-Body Intelligence models and blood tests. | Healthcare & Biotech | Oct 2025Series A | Page + round | |
| The company generates and utilizes multimodal aging datasets and AI-driven drug discovery for age-related disease | Healthcare & Biotech | Portfolio page | ||
| The company uses cookies to analyze website traffic and optimize user experience. | Media & EntertainmentHealthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- lumagroup.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 25 Mar 2025
- Companies checked
- 8
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Luma Group's profile as data
Pull Luma Group's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/lumagroup.com
# also
GET /v1/firms/lumagroup.com/portfolio
GET /v1/firms/lumagroup.com/coinvestors
GET /v1/firms/lumagroup.com/news